RBMS3 is a novel candidate gene for suppressing tumors as in esophageal squamous cell carcinoma (ESCC) [23], breast cancer [24], nasopharyngeal cancer (NPC) [25], and lung squamous cell carcinoma (LSCC) [26]. Here, RBMS3 is linked to breast carcinoma.